Nishkam Pharmacy Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 08341597

Nishkam Pharmacy Limited

Filleted Financial Statements

31 March 2025

Nishkam Pharmacy Limited

Statement of Financial Position

31 March 2025

	2025	2024
Note	£	£

Fixed assets

Tangible assets	6	59,251	63,577

Current assets

Stocks		64,081	49,181
Debtors	7	237,716	203,390
Cash at bank and in hand		28,118	116,802
		---------	---------
		329,915	369,373

Creditors: amounts falling due within one year	8	147,333	177,784
		---------	---------
Net current assets		182,582	191,589
		---------	---------
Total assets less current liabilities		241,833	255,166

Provisions	9	2,897	3,069
		---------	---------
Net assets		238,936	252,097
		---------	---------

Capital and reserves

Called up share capital	12	1	1
Share premium account	13	151,312	151,312
Profit and loss account	13	87,623	100,784
		---------	---------
Shareholder funds		238,936	252,097
		---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements were approved by the board of directors and authorised for issue on 23 December 2025 , and are signed on behalf of the board by:

S S Sandhu
Director

Company registration number: 08341597

Nishkam Pharmacy Limited

Notes to the Financial Statements

Year ended 31 March 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 21 Soho Road, Handsworth, Birmingham, B21 9SN.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Disclosure exemptions

The entity satisfies the criteria of being a small entity as defined in FRS102 and section 382 of the Companies Act 2006 and has taken advantage of the disclosure exemptions available under paragraph 1A.7 of FRS102.

Revenue recognition

Turnover arrives from the sale of preparing, dispensing and reviewing of drugs and other clinical service. Turnover is recognised at the fair value of considerations at point of sale.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Intangible assets

Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Computer software	-	evenly over its estimated useful life of nil years

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Freehold property	-	4% straight line
Fixtures and fittings	-	15% reducing balance
Motor vehicles	-	15% reducing balance

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 12 (2024: 14 ).

5. Intangible assets

	Computer software
	£
Cost
At 1 April 2024 and 31 March 2025	20,006
	--------
Amortisation
At 1 April 2024 and 31 March 2025	20,006
	--------
Carrying amount
At 31 March 2025	–
	--------
At 31 March 2024	–
	--------

6. Tangible assets

	Freehold property	Fixtures and fittings	Motor vehicles	Total
	£	£	£	£
Cost
At 1 April 2024	85,492	26,839	9,682	122,013
Additions	–	1,785	–	1,785
	--------	--------	-------	---------
At 31 March 2025	85,492	28,624	9,682	123,798
	--------	--------	-------	---------
Depreciation
At 1 April 2024	38,072	14,334	6,030	58,436
Charge for the year	3,420	2,143	548	6,111
	--------	--------	-------	---------
At 31 March 2025	41,492	16,477	6,578	64,547
	--------	--------	-------	---------
Carrying amount
At 31 March 2025	44,000	12,147	3,104	59,251
	--------	--------	-------	---------
At 31 March 2024	47,420	12,505	3,652	63,577
	--------	--------	-------	---------

7. Debtors

	2025	2024
	£	£
Trade debtors	107,051	99,345
Amounts owed by group undertakings	92,942	80,662
Prepayments and accrued income	2,312	1,368
Other debtors	35,411	22,015
	---------	---------
	237,716	203,390
	---------	---------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	120,193	134,658
Amounts owed to group undertakings	–	10,000
Accruals and deferred income	24,151	29,669
Social security and other taxes	2,416	2,718
Other creditors	573	739
	---------	---------
	147,333	177,784
	---------	---------

9. Provisions

	Deferred tax (note 10)
	£
At 1 April 2024	3,069
Additions	( 172)
	-------
At 31 March 2025	2,897
	-------

10. Deferred tax

The deferred tax included in the statement of financial position is as follows:

	2025	2024
	£	£
Included in provisions (note 9)	2,897	3,069
	-------	-------

The deferred tax account consists of the tax effect of timing differences in respect of:

	2025	2024
	£	£
Accelerated capital allowances	2,897	3,069
	-------	-------

11. Employee benefits

Defined contribution plans

The amount recognised in profit or loss as an expense in relation to defined contribution plans was £ 3,639 (2024: £ 4,274 ).

12. Called up share capital

Issued, called up and fully paid

	2025		2024
	No.	£	No.	£
Ordinary shares of £ 1 each	1	1	1	1
	----	----	----	----

13. Reserves

Share premium account - This reserve records the amount above the nominal value received for shares sold, less transaction costs. Profit and loss account - This reserve records retained earnings and accumulated losses.

14. Summary audit opinion

The auditor's report dated 23 December 2025 was unqualified .

The senior statutory auditor was Hannah Justice FCA FCCA , for and on behalf of BSN Associates Limited .

15. Related party transactions

During the year the following connected parties and transactions were identified: Nishkam Healthcare Trust Nishkam Pharmacy is a 100% owned subsidiary of Nishkam Healthcare Trust. Guru Nanak Nishkam Sewa Jatha (Birmingham) UK An unincorporated charity in which the trustee Mohinder Singh Ahluwalia and J PS Chandan were trustee. Nishkam Healthcare Trust operates from premises at 21 Soho Road, a freehold held by Guru Nanak Nishkam Sewak Jatha (Birmingham) UK. Nishkam Dental Care Limited A 100% subsidiary of Nishkam Healthcare Trust. Nishkam Civic Association A charity in which the trustee Mohinder Singh Ahluwalia, P S Jhutti and J P S Chandan were trustees. Nishkam Security Limited A 25% owned subsidiary of Nishkam Healthcare Trust. Nishkam School Trust A charity in which the trustee Mohinder Singh Ahluwalia was the patron. NPVR Limited A 100% owned subsidiary of Nishkam Healthcare Limited. Sangat Trust A charitable company and its subsidiaries in which Trustee Mohinder Singh Ahluwalia has been a trustee. During the year the company made sales to the following related parties:

	2025	2024
	£	£
Guru Nanak Nishkam Sewak Jatha (Birmingham) UK	5,564	7,519
Nishkam Healthcare Trust	66	204
Nishkam School Trust	1,148	1,931
NPVR Limited	53	7,515

During the year the company made the following purchases from related parties:

	2025	2024
	£	£
Nishkam Healthcare Trust	900	1,304

During the year the company purchased the following services from related parties:

		2025	2024
		£	£

Nishkam Healthcare Trust	12,000	12,000
Nishkam Security	1,125	–

During the year the company made the following donations to related parties:

	2025	2024
	£	£
Nishkam Healthcare Trust	450	24,000

The following amounts were due from related parties:

	2025	2024
	£	£
Nishkam School Trust	–	379
Nishkam Healthcare Trust	10,193	1,500
NPVR Limited	82,756	79,162

The following amounts were due to related parties:

	2025	2024
	£	£
Nishkam Healthcare Trust	18,000	22,375

16. Controlling party

The ultimate controlling party is Nishkam Healthcare Trust, who own 100% of the share capital of Nishkam Pharmacy Limited .